It's rare that results of a new study, especially with a product focus, excite me. That's not to say I don't appreciate reading about a vendor's award, or the latest Alzheimer's study, but I see these more objectively than, say, the release Monday about a new option for glaucoma treatment. That's news where I thought, "Wow!"
A contact lens that can deliver glaucoma medication may signal a new era for treatment of the eye disease. Researchers at Massachusetts Eye and Ear/Harvard Medical School Department of Ophthalmology, Boston Children's Hospital and Massachusetts Institute of Technology developed a lens that can deliver large amounts of latanoprost, which is a common glaucoma treatment drug.